Skip to main content
. 2022 Aug 31;36(10):e24685. doi: 10.1002/jcla.24685

TABLE 1.

STEMI patients' characteristics

Items STEMI patients (N = 373)
Demographics
Age (years), mean ± SD 61.9 ± 10.4
Gender, n (%)
Female 95 (25.5)
Male 278 (74.5)
BMI (kg/m2), mean ± SD 24.6 ± 3.3
Current smoker, n (%) 145 (38.9)
Medical history
History of hypertension, n (%) 258 (69.2)
History of hyperlipidemia, n (%) 168 (45.0)
History of DM, n (%) 96 (25.7)
Laboratory findings
WBC (109/L), median (IQR) 10.0 (7.6–12.7)
FBG (mmol/L), median (IQR) 5.2 (4.4–6.3)
Scr (μmol/L), median (IQR) 84.6 (73.6–100.4)
TG (mmol/L), median (IQR) 1.8 (1.0–2.5)
TC (mmol/L), median (IQR) 4.6 (3.8–5.4)
LDL‐C (mmol/L), median (IQR) 3.1 (2.3–3.9)
HDL‐C (mmol/L), median (IQR) 1.0 (0.9–1.2)
CRP (mg/L), median (IQR) 4.7 (3.2–6.3)
cTnI (ng/ml), median (IQR) 4.4 (3.0–6.30)
CK‐MB (ng/ml), median (IQR) 32.5 (18.3–53.9)
Disease features
Symptom‐to‐balloon time (min), median (IQR) 190.0 (140.0–280.0)
Infarct size a (%), median (IQR) 23.0 (17.0–29.0)
Culprit lesion, n (%)
Left anterior descending artery 159 (42.6)
Left circumflex artery 75 (20.1)
Right coronary artery 139 (37.3)
Multivessel disease, n (%) 158 (42.4)
Treatment information
Thrombus aspiration, n (%) 82 (22.0)
Number of implanted stents, n (%)
1 285 (76.4)
2 88 (23.6)
Type of stent, n (%)
Sirolimus‐eluting stent 253 (67.8)
Everolimus‐eluting stent 120 (32.2)
Stent diameter (mm), median (IQR) 3.0 (3.0–3.5)
Total stent length (mm), median (IQR) 33.0 (23.0–38.0)

Abbreviations: BMI, body mass index; CK‐MB, creatine kinase‐myocardial band; CRP, C‐reactive protein; cTnI, cardiac troponin I; DM, diabetes mellitus; FBG, fasting blood glucose; HDL‐C, high‐density lipoprotein cholesterol; IQR, interquartile range; LDL‐C, low‐density lipoprotein cholesterol; Scr, serum creatinine; SD, standard deviation; STEMI, ST‐segment elevation myocardial infarction; TC, total cholesterol; TG, triglyceride; WBC, white blood cell.

a

Evaluated on the second or third day after PCI.